We investigated the effects of acute adrenal steroid treatment on spatial memory using the Y-maze and employing adrenal steroid receptor antagonists and agonists. For receptor activation, adrenalectomized rats were injected 2 h prior to their first Y-maze trial with sesame oil (adrenalectomy or SHAM), stress levels of corticosterone, a Type I receptor agonist (aldosterone), or a Type II receptor agonist (RU362). For receptor inactivation, unoperated rats were injected with a Type I receptor antagonist (RU318), a Type II receptor antagonist (RU555), sesame oil, or not injected at all. The findings indicated that spatial memory was impaired when the Type II receptors were blocked (RU555) or highly occupied (corticosterone or RU362) and normal for the other treatment conditions. These data suggest that the Type II receptors may be responsible for the inverted U-shaped relationship between spatial memory and corticosterone levels reported by others.
Recent studies performed in rats have reported that corticosteroid levels demonstrate an inverted U-shaped relationship with hippocampal response to activation (Diamond, Bennett, Fleshner, & Rose, 1992; Kerr, Huggett, & Abraham, 1994) and spatial memory performance (Yau, Olsson, Morris, Meaney, & Seckl, 1995) . One interpretation of these data, which will be referred to as the "Opposing Receptor Hypothesis," is that the enhancement of hippocampal function in adrenalectomized rats after corticosteroid treatment is caused by Type I receptor activation whereas the impairment of hippocampal function is caused by Type II receptor activation. This is because Type I receptors are activated at low basal levels of corticosteroids, while Type II receptors are activated at high stress levels of corticosteroids (de Kloet, 1991; Reul & de Kloet, 1985) . That the two receptor types may mediate opposing functional processes of the hippocampus is supported by studies showing that adrenalectomized rats injected with Type I receptor agonists show normal long Preliminary results of this study were presented at the 1996 Society for Neuroscience meeting.
